Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational

Abbott i-STAT High Sensitivity Troponin I Study

ClinicalTrials.gov ID: NCT05629572

Public ClinicalTrials.gov record NCT05629572. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 8, 2026, 12:20 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Clinical Evaluation of the i-STAT High Sensitivity Troponin I Test to Aid in the Diagnosis of Myocardial Infarction (MI)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The goal of this observational multi-center study is to evaluate the clinical performance of the i-STAT hs-TnI test (i-STAT High Sensitivity Troponin I) using the investigational i-STAT hs-TnI cartridge for the proposed intended use as an aid in the diagnosis and treatment of myocardial infarction (MI). The cartridge measures cardiac troponin I (cTnI) in whole blood or plasma samples using the i-STAT 1 Analyzer or i-STAT Alinity Instrument. Subjects presenting to the emergency department (ED) with chest discomfort or equivalent ischemic symptoms suggestive of Acute Coronary Syndrome (ACS) who are enrolled in this study will be asked to provide blood samples for testing.

Study identification

NCT ID
NCT05629572
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Lead sponsor
Abbott Point of Care
Industry
Enrollment
3,697 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 1, 2022
Primary completion
Feb 5, 2024
Completion
Mar 10, 2024
Last update posted
Sep 18, 2024

2022 – 2024

United States locations

U.S. sites
28
U.S. states
21
U.S. cities
28
Facility City State ZIP Site status
Mercy Gilbert Medical Center Chandler Arizona 85224
University of California at San Francisco San Francisco California 94110
Stanford Medical Center Stanford California 94305
Geroge Washington University Washington D.C. District of Columbia 20037
Tampa General Hospital Tampa Florida 33606
Indiana University Indianapolis Indiana 46202
University of Kansas Medical Center Kansas City Kansas 66160
Kentucky Clinical Trials Labatory Louisville Kentucky 40202
Henry Ford Health System Detroit Michigan 48202
Hennepin Healthcare (Research Institute/Minneapolis Medical Research Foundation) Minneapolis Minnesota 55404
Mayo Clinic Rochester Minnesota 55906
Washington University St Louis Missouri 63110
University Medical Center of Southern Nevada Las Vegas Nevada 89012
Cooper University Hospital Camden New Jersey 08103
University of New Mexico Albuquerque New Mexico 87131
Stony Brook University Stony Brook New York 11974-8167
Wake Forest Baptist Health Winston-Salem North Carolina 27151
University of Cincinnati Medical Center Cincinnati Ohio 45267
Ohio State University Medical Center Columbus Ohio 43210
Penn State University Hershey Medical Center Hershey Pennsylvania 17033
Thomas Jefferson University Hospital Philadelphia Pennsylvania 19107
Medical University of South Carolina Charleston South Carolina 29425
Florence Medical Centre (MUSC Health) Florence South Carolina 29505
University of Texas Southwestern Medical Center Dallas Texas 75390-8579
Baylor College of Medicine Houston Texas 77030
Baylor Scott and White Healthcare Temple Texas 76508
University of Virginia Charlottesville Virginia 22903
Eastside Research Associates Redmond Washington 98052

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05629572, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 18, 2024 · Synced Sep 8, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05629572 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →